Wellnex Life Limited (Wellnex, WNX or Company) (ASX: WNX), owner and developer of some of Australia's leading health brands, has recently published a key ASX announcement.
Wellnex Life Limited (ASX) ("Wellnex Life" or the "Company"), is pleased to provide their investor presentation for the commencement of the marketing campaign for the dual listing of the Company on the London Stock Exchange.
Announcement Highlights
- Strong Revenue Growth: Revenue of 112% for the 1HFY25 compared to 1HFY24, with brand revenue up 182% in the same period.
- Global Partnerships: Licensing arrangement with Haleon to supply Wellnex Life developed products globally for leading pain relief brand.
- Growth Opportunities: Further expansion opportunities in international market with branded business and IP Licensing.
A huge congratulations to George Karafotias, Zack Bozinovski, the board and the team at WNX for reaching this milestone.
Read the full Wellnex Life Company Update here.
To learn more about Wellnex Life and stay up to date with investor information, subscribe to the Company's Chairman’s List.
